Search research articles
Contact Us
Filters
Showing results (21-30 of 30) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 30 results.
Cancer Practice
|
February 14, 1998
Angiogenesis inhibitors. A promising role in cancer therapy
Y F Hui, R J Ignoffo
Cancer Practice
|
September 1, 1995
Vinorelbine tartrate
B M Chan, R J Ignoffo
Cancer Practice
|
September 1, 1996
Liposomal doxorubicin
K F Linsky, R J Ignoffo
Cancer Chemotherapy and Pharmacology
|
January 1, 1981
Pharmacokinetics of methotrexate administered via the hepatic artery
R J Ignoffo, S Oie, M A Friedman
Journal of Oral Medicine
|
January 1, 1984
Intravenous antibiotics, avoiding complications
R A Smith, V G Pons, R J Ignoffo
Annals of Internal Medicine
|
May 1, 1984
Hepatic arterial chemotherapy for colorectal cancer metastatic to the liver
R J Stagg, B J Lewis, M A Friedman, et al.
Drug Intelligence & Clinical Pharmacy
|
September 1, 1983
Adjusting heparin infusion rates from the initial response to activated coagulation time
P G Hattersley, J C Mitsuoka, R J Ignoffo, et al.
Cancer
|
February 1, 1986
Toxicities and complications of implanted pump hepatic arterial and intravenous floxuridine infusion
D C Hohn, A A Rayner, J S Economou, et al.
Cancer Treatment Reports
|
July 1, 1984
Phase II study of sequential methotrexate and 5-FU plus mitomycin and leucovorin in patients with disseminated large bowel cancer: a Northern California Oncology Group study
R J Ignoffo, M A Friedman, M Gribble, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 1, 1989
A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: the Northern California Oncology Group trial
D C Hohn, R J Stagg, M A Friedman, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 30) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 30 results.
Cancer Practice
|
February 14, 1998
Angiogenesis inhibitors. A promising role in cancer therapy
Y F Hui, R J Ignoffo
Cancer Practice
|
September 1, 1995
Vinorelbine tartrate
B M Chan, R J Ignoffo
Cancer Practice
|
September 1, 1996
Liposomal doxorubicin
K F Linsky, R J Ignoffo
Cancer Chemotherapy and Pharmacology
|
January 1, 1981
Pharmacokinetics of methotrexate administered via the hepatic artery
R J Ignoffo, S Oie, M A Friedman
Journal of Oral Medicine
|
January 1, 1984
Intravenous antibiotics, avoiding complications
R A Smith, V G Pons, R J Ignoffo
Annals of Internal Medicine
|
May 1, 1984
Hepatic arterial chemotherapy for colorectal cancer metastatic to the liver
R J Stagg, B J Lewis, M A Friedman, et al.
Drug Intelligence & Clinical Pharmacy
|
September 1, 1983
Adjusting heparin infusion rates from the initial response to activated coagulation time
P G Hattersley, J C Mitsuoka, R J Ignoffo, et al.
Cancer
|
February 1, 1986
Toxicities and complications of implanted pump hepatic arterial and intravenous floxuridine infusion
D C Hohn, A A Rayner, J S Economou, et al.
Cancer Treatment Reports
|
July 1, 1984
Phase II study of sequential methotrexate and 5-FU plus mitomycin and leucovorin in patients with disseminated large bowel cancer: a Northern California Oncology Group study
R J Ignoffo, M A Friedman, M Gribble, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 1, 1989
A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: the Northern California Oncology Group trial
D C Hohn, R J Stagg, M A Friedman, et al.
Page
of 3